SLC9A6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.30526750203353E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.41550000188585E-08 |
Normal-vs-Stage2 |
4.79370000361357E-08 |
Normal-vs-Stage3 |
9.01767549521537E-12 |
Normal-vs-Stage4 |
7.28869999910842E-08 |
Stage1-vs-Stage2 |
5.635600E-02 |
Stage1-vs-Stage3 |
6.664500E-03 |
Stage1-vs-Stage4 |
7.498500E-02 |
Stage2-vs-Stage3 |
9.022200E-01 |
Stage2-vs-Stage4 |
8.925000E-01 |
Stage3-vs-Stage4 |
9.661800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.65432120727382E-12 |
Normal-vs-AfricanAmerican |
2.24749996391438E-09 |
Normal-vs-Asian |
8.081900E-02 |
Caucasian-vs-AfricanAmerican |
1.756430E-01 |
Caucasian-vs-Asian |
6.021200E-01 |
AfricanAmerican-vs-Asian |
2.644600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.43813907636104E-12 |
Normal-vs-Female |
3.70760000478754E-09 |
Male-vs-Female |
7.940000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.47030000291682E-08 |
Normal-vs-Age(41-60Yrs) |
2.94899993313891E-10 |
Normal-vs-Age(61-80Yrs) |
4.57019999622332E-09 |
Normal-vs-Age(81-100Yrs) |
1.432650E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.323990E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.451430E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.623200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.235600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.597800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.313400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.142300E-02 |
Normal-vs-Grade 2 |
6.52320000238404E-08 |
Normal-vs-Grade 3 |
7.65900010080145E-10 |
Normal-vs-Grade 4 |
4.75529999821589E-08 |
Grade 1-vs-Grade 2 |
5.593200E-01 |
Grade 1-vs-Grade 3 |
2.293600E-01 |
Grade 1-vs-Grade 4 |
7.317700E-02 |
Grade 2-vs-Grade 3 |
8.170100E-02 |
Grade 2-vs-Grade 4 |
4.879800E-02 |
Grade 3-vs-Grade 4 |
2.701400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.2180999999778E-06 |
Normal-vs-ccB subtype |
2.93509661020153E-11 |
ccA subtype-vs-ccB subtype |
7.398000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.86729995302437E-09 |
Normal-vs-N1 |
5.159600E-04 |
N0-vs-N1 |
3.996600E-01 |
|
|